CINECA IRIS Institutional Research Information System

D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.251
AS - Asia 783
EU - Europa 645
Continente sconosciuto - Info sul continente non disponibili 242
SA - Sud America 41
AF - Africa 13
OC - Oceania 3
Totale 2.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.147
IT - Italia 479
BD - Bangladesh 399
CN - Cina 116
SG - Singapore 98
HK - Hong Kong 88
FR - Francia 47
CA - Canada 44
VN - Vietnam 37
DE - Germania 33
BR - Brasile 27
GB - Regno Unito 22
PL - Polonia 20
NL - Olanda 15
MX - Messico 10
CR - Costa Rica 9
HN - Honduras 8
IN - India 8
JM - Giamaica 8
NI - Nicaragua 7
ES - Italia 5
KR - Corea 5
SV - El Salvador 5
AR - Argentina 4
GT - Guatemala 4
ID - Indonesia 4
TR - Turchia 4
TT - Trinidad e Tobago 4
AU - Australia 3
BE - Belgio 3
CO - Colombia 3
EC - Ecuador 3
IE - Irlanda 3
IQ - Iraq 3
SA - Arabia Saudita 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
JP - Giappone 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
PR - Porto Rico 2
RS - Serbia 2
TH - Thailandia 2
UA - Ucraina 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
MG - Madagascar 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.736
Salva come PNG Salva come JPEG
Città #
San Jose 205
New York 184
Ashburn 101
Hong Kong 88
Beijing 66
Rome 51
Singapore 51
Milan 48
Santa Clara 48
Los Angeles 46
Buffalo 37
Naples 30
Frankfurt am Main 27
Toronto 20
Turin 19
Hillsboro 18
Phoenix 18
Florence 17
Bologna 15
Chicago 14
Warsaw 13
Genoa 12
Vigonza 12
Brescia 11
Dallas 11
Montreal 11
Catania 10
Hanoi 10
Ho Chi Minh City 10
Rimini 10
Charlotte 9
Figino 9
Mexico City 8
Palermo 8
San José 8
Seattle 7
Venice 7
Bari 6
Houston 6
Managua 6
Pasadena 6
Philadelphia 6
San Diego 6
Atlanta 5
Brooklyn 5
Council Bluffs 5
Las Vegas 5
Mumbai 5
Seoul 5
Tampa 5
Verona 5
Cagliari 4
Denver 4
Fort Worth 4
Guatemala City 4
Newark 4
Orem 4
Port of Spain 4
Reston 4
San Mauro Pascoli 4
San Salvador 4
Alexandria 3
Amsterdam 3
Ancona 3
Baghdad 3
Da Nang 3
Dublin 3
Kingston 3
London 3
Madrid 3
Oakland 3
Padua 3
Pescara 3
Queens 3
Ravenna 3
Riyadh 3
Thái Nguyên 3
Washington 3
Wilmington 3
Wroclaw 3
Arezzo 2
Barletta 2
Bergamo 2
Brugnera 2
Brussels 2
Calgary 2
Casarsa della Delizia 2
Cerdanyola del Vallès 2
Chennai 2
City of London 2
El Progreso 2
Elizabeth 2
Ennis 2
Gilroy 2
Greenville 2
Guayaquil 2
Hackney 2
Hampton 2
Jackson 2
Jacksonville 2
Totale 1.482
Salva come PNG Salva come JPEG
Nome #
Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany 66
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 63
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 62
Efficacy and safety of rituximab and low dosage of glucocorticoids for ANCA associated vasculitis interstitial lung disease: a proof-of-concept study 61
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer 56
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 43
Uncovering Sex and Gender Differences in Sarcoidosis: A Systematic Review of Current Evidence 42
Diagnostic Performance of CLEIA Versus FEIA for KL-6 Peripheral and Alveolar Concentrations in Fibrotic Interstitial Lung Diseases: A Multicentre Study 40
Strain echocardiography is a promising tool for the prognostic assessment of sarcoidosis 38
Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study 38
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 37
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 37
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 37
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 35
A Precision Surgery Framework for Lung Resection: Robotic, Video-Assisted, and Open Segmentectomy 32
Whole-genome sequencing reveals host factors underlying critical COVID-19 30
Clinical phenotyping in sarcoidosis management 30
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 29
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 29
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 28
Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis 28
Donor-Recipient Mismatch in Lung Transplantation: The Role of Graft Sizing in Clinical Outcomes 27
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 26
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 25
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 25
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 25
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 25
Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease 24
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review 24
Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis 23
Imbalance of Lymphocyte Subsets and CD45RA-Expressing Cells in Intrathoracic Lymph Nodes, Alveolar Compartment and Bloodstream of Pulmonary Sarcoidosis Patients 23
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach 22
Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction 22
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 22
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort 21
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 21
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 21
An explainable model of host genetic interactions linked to COVID-19 severity 21
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 21
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? 21
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 21
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 21
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 21
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 21
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 20
Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatment 20
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 19
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 19
Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis 18
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma 18
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 18
A multicenter study of extracellular vesicles profile in bronchoalveolar lavage from patients affected by IPF, HP and sarcoidosis 17
Peripheral biomarkers' panel for severe COVID-19 patients 17
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 17
Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab 16
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 16
Effects of rituximab therapy on B cell differentiation and depletion 16
Online survey on existing sarcoidosis registries and biobanks: An ERN lung initiative 16
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 16
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 16
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 16
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 15
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 15
Natural killer T-cells in asthma pathogenesis and treatment: old problems and future perspectives 15
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis 15
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 15
Comparative Serum Protein Profiles in IPF Patients Before and After Nintedanib Therapy 15
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 15
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 15
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 15
POS0823 KL-6 IN ANCA-ASSOCIATED VASCULITIS PATIENTS WITH AND WITHOUT ILD: A MACHINE LEARNING APPROACH 15
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital 15
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 15
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 14
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 14
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 14
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 14
Serum ferritin as a specific biomarker of anti-MDA5-interstitial lung disease: a multicenter, case–control study in observational and validation datasets 14
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 14
Nk and t cell immunological signatures in hospitalized patients with covid-19 13
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series 13
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 13
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 13
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 13
Serial autoantibody detection in interstitial lung diseases: should they be repeated at follow-up? 13
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 13
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 13
Immune-Checkpoint expression on CD4, CD8 and NK cells in blood, BAL and lymph nodes of sarcoidosis 12
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica 12
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica 12
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis 12
Clinical and molecular characterization of COVID-19 hospitalized patients 12
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 12
Safety and uptake of solid lipid nanoparticles by airway epithelial cells: an in vitro study 12
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 12
A first update on mapping the human genetic architecture of COVID-19 11
SARS-CoV-2 and Dysphagia: A Retrospective Analysis of COVID-19 Patients with Swallowing Disorders 11
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 11
The value of urinary calcium as biomarker in chronic sarcoidosis 11
T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients 11
Totale 2.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202513 0 0 0 0 0 0 0 0 3 8 2 0
2025/20262.225 9 3 11 14 5 1 93 465 284 505 390 445
2026/2027740 273 356 109 2 0 0 0 0 0 0 0 0
Totale 2.978